- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00505518
Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home
July 9, 2013 updated by: Albert Yeung, Massachusetts General Hospital
Feasibility and Effectiveness of Telepsychiatry for Collaborative Management of Chinese Americans With Psychiatric Disorders in a Nursing Home
The current use of telepsychiatry, or psychiatric care using videoconferencing, is very limited.
The present study investigates the use of this method with a depressed Chinese American population in a nursing home.
It is believed that this population can benefit from telepsychiatric treatment when used in collaboration with the primary care they receive in the nursing home.
Study Overview
Status
Completed
Conditions
Detailed Description
Individuals at the South Cove Manor nursing home will be referred to this study if they are experiencing depression.
After meeting with the Principal Investigator (a psychiatrist), he will collaborate with the primary care physician and the nursing home staff to establish a treatment plan for the patient.
Videoconferencing will be used by the P.I. for regular psychiatric visits with the patient as well as meetings with the nursing home staff to coordinate care for the patient.
After collaboration between the two groups, treatment suggestions will be given to the patient's primary care physician (PCP) to implement in the primary care setting.
The patient's symptomology, mood, satisfaction of life and side effects of medication will be recorded regularly to measure the effects of treatment for analysis.
Study Type
Interventional
Enrollment (Actual)
9
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Depression and Clinical Research Program at Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02118
- South Cove Manor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Major Depressive Disorder
- Patient at South Cove Manor Nursing Home
- Referred by nursing staff for psychiatric consultation
Exclusion Criteria:
- Not competent to participate in psychiatric interviews
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Mean Scores on Clinical Global Impressions
Time Frame: Baseline, 30 days or 60 days (length depended on clinical needs of patients)
|
Minimum score - 1 (better outcome) Maximum score - 7 (worse outcome)
|
Baseline, 30 days or 60 days (length depended on clinical needs of patients)
|
Patient/Family Telepsychiatry Service Satisfaction Survey
Time Frame: 30 days or 60 days (length depended on clinical needs of patients)
|
Patients' (or their family members' for those who had severe cognitive deficits) satisfaction with the telepsychiatry services were surveyed using a satisfaction questionnaire specifically designed for this study.
The satisfaction questionnaire is a scale with three choices: "not satisfied", "satisfied", and "highly satisfied."
|
30 days or 60 days (length depended on clinical needs of patients)
|
Nurse Telepsychiatry Services Satisfaction Questionnaire
Time Frame: 30 days or 60 days (length depended on clinical needs of patients)
|
The charge nurse's satisfaction with the telepsychiatry services were surveyed using a satisfaction questionnaire specifically designed for this study.
The satisfaction questionnaire is a scale with three choices: "not satisfied", "satisfied", and "highly satisfied."
|
30 days or 60 days (length depended on clinical needs of patients)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Albert Yeung, S., M.D., Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2006
Primary Completion (ACTUAL)
November 1, 2007
Study Completion (ACTUAL)
November 1, 2007
Study Registration Dates
First Submitted
July 19, 2007
First Submitted That Met QC Criteria
July 19, 2007
First Posted (ESTIMATE)
July 23, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
September 17, 2013
Last Update Submitted That Met QC Criteria
July 9, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006-P-001508
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on Psychotropic medication (at discretion of psychiatrist)
-
University Hospital, MontpellierCompletedPatient Hospitalized in Internal Medicine UnitFrance
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Health services; Alberta...Active, not recruiting
-
University of California, San FranciscoRecruiting
-
Cedars-Sinai Medical CenterRecruiting
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Essen; Philipps University Marburg Medical Center; Helmut...RecruitingDepressive Symptoms | Expectations | AntidepressantsGermany
-
Sofia Perea, Director Clinical Trials Unit.UnknownCarcinoma, Pancreatic DuctalSpain
-
Erasme University HospitalUniversity of Liege; Universitair Ziekenhuis Brussel; University Hospital, Lille and other collaboratorsCompletedBacteriuria | Urinary Tract Infections | Kidney Transplantation | Asymptomatic BacteriuriaBelgium, France
-
University of ManitobaCompletedAbdominal Aortic Aneurysm UncomplicatedCanada
-
Emory UniversityNational Institute of Mental Health (NIMH); All India Institute of Medical... and other collaboratorsCompletedDepression | Diabetes | Cardiovascular Risk FactorIndia
-
Assistance Publique - Hôpitaux de ParisTerminatedHeart-lung Transplant RejectionFrance